 LOS ANGELES , Oct. 18, 2021 PRNewswire -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Revance Therapeutics, Inc. Revance or the Company NASDAQ: RVNC for violations of the securities laws. The investigation focuses on whether the Company issued false andor misleading statements andor failed to disclose information pertinent to investors. 